USA Financial Formulas Acquires New Holdings in Encompass Health Corporation $EHC

Key Points

• USA Financial Formulas has acquired a new stake of 2,103 shares in Encompass Health Corporation, valued at approximately $258,000, in the 2nd quarter.
• Wall Street analysts show positive sentiment towards Encompass Health, with multiple price adjustments, including an increase from $135.00 to $140.00 by KeyCorp and from $140.00 to $150.00 by UBS Group.
• Encompass Health recently announced a quarterly dividend increase from $0.17 to $0.19 per share, reflecting a commitment to returning value to shareholders.

USA Financial Formulas acquired a new stake in Encompass Health Corporation (NYSE:EHC - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 2,103 shares of the company's stock, valued at approximately $258,000.

Several other institutional investors have also recently bought and sold shares of EHC. Wealth Enhancement Advisory Services LLC lifted its stake in Encompass Health by 46.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 19,204 shares of the company's stock valued at $1,774,000 after acquiring an additional 6,053 shares in the last quarter. GAMMA Investing LLC lifted its stake in Encompass Health by 12,207.6% in the 1st quarter. GAMMA Investing LLC now owns 239,628 shares of the company's stock valued at $24,270,000 after acquiring an additional 237,681 shares in the last quarter. Parallel Advisors LLC lifted its stake in Encompass Health by 25.0% in the 1st quarter. Parallel Advisors LLC now owns 2,319 shares of the company's stock valued at $235,000 after acquiring an additional 464 shares in the last quarter. NBC Securities Inc. lifted its stake in Encompass Health by 140,033.3% in the 1st quarter. NBC Securities Inc. now owns 4,204 shares of the company's stock valued at $425,000 after acquiring an additional 4,201 shares in the last quarter. Finally, Merit Financial Group LLC lifted its stake in Encompass Health by 4.1% in the 1st quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock valued at $427,000 after acquiring an additional 166 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on EHC shares. KeyCorp upped their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 16th. UBS Group upped their price objective on Encompass Health from $140.00 to $150.00 and gave the stock a "buy" rating in a research note on Thursday. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a research note on Thursday, June 5th. Finally, Bank of America upped their price objective on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $139.86.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares of the company's stock, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 2.00% of the company's stock.

Encompass Health Stock Down 0.8%

EHC stock opened at $123.58 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The stock has a market capitalization of $12.45 billion, a price-to-earnings ratio of 24.18, a PEG ratio of 2.18 and a beta of 0.93. The business's fifty day moving average price is $120.94 and its two-hundred day moving average price is $115.37. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.86.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.20. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company's quarterly revenue was up 12.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, equities analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. This is an increase from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Encompass Health's payout ratio is currently 14.87%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.